Method of Producing Collagenase
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 62/477,846, filed Mar 28, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,448,615 | Method of Purifying and Isolating Collagenase In force · High confidence | Endo Operations Limited | In force | High confidence | ||
| US 12,644,108 | Process Intermediate in the Purification of Collagenase Drug Substances In force · Medium confidence | Endo Operations Limited | In force | Medium confidence | ||
| US 11,473,074 | Method of Producing Collagenase In force · High confidence | Endo Operations Limited | In force | High confidence | ||
| Application 19/336,963 | Method of Purifying and Isolating Collagenase Pending Not granted | Endo Operations Limited | Pending | Not granted | ||
| Application 19/651,932 | Method of Producing Collagenase Pending Not granted | Endo Operations Limited | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Endo Operations Limited.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.